Liwei Pang
Impact in
-
- Gallbladder and Bile Duct Disorders
-
- Pancreatic and Hepatic Oncology Research
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- Pancreatic and Hepatic Oncology Research 2
-
- Immune Cell Function and Interaction 4
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 2
- Co-authors
- Wanlin Dai (10 shared papers)Jing Kong (8 shared papers)Jing Kong (4 shared papers)Shuodong Wu (6 shared papers)Shuodong Wu (4 shared papers)Yuwen Wang (2 shared papers)Yuting Zheng (5 shared papers)Shaojie Yang (2 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)Carcinogenesis (2 papers)Cancer Immunology Immunotherapy (2 papers)Frontiers in Oncology (2 papers)BMC Anesthesiology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Liwei Pang
31 papers receiving 317 citations
Peers
Comparison fields: 5 of 65
- Pulmonary and Respiratory Medicine 74
- Oncology 63
- Anesthesiology and Pain Medicine 11
- Cancer Research 31
- Hepatology 12
Countries citing papers authored by Liwei Pang
This map shows the geographic impact of Liwei Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Pang more than expected).
Fields of papers citing papers by Liwei Pang
This network shows the impact of papers produced by Liwei Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Pang. The network helps show where Liwei Pang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liwei Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 29 | |
| 2 | 2022 | 27 | |
| 3 | 2021 | 27 | |
| 4 | 2021 | 26 | |
| 5 | 2018 | 23 | |
| 6 | 2018 | 22 | |
| 7 | 2024 | 21 | |
| 8 | 2021 | 19 | |
| 9 | 2024 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2020 | 14 | |
| 12 | 2018 | 12 | |
| 13 | 2021 | 10 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 7 | |
| 16 | 2014 | 7 | |
| 17 | 2021 | 6 | |
| 18 | 2022 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2024 | 3 |
About Liwei Pang
Liwei Pang is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 33 papers that have together received 321 indexed citations. Recurring topics across this work include Gallbladder and Bile Duct Disorders (5 papers), Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), T-cell and B-cell Immunology (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Caveolin-1 and cellular processes (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (74 citations), Oncology (63 citations), Anesthesiology and Pain Medicine (11 citations), Cancer Research (31 citations) and Hepatology (12 citations). Liwei Pang has collaborated with scholars based in China and United States. Frequent co-authors include Wanlin Dai, Jing Kong, Jing Kong, Shuodong Wu, Shuodong Wu, Yuwen Wang, Yuting Zheng, Shaojie Yang, Yuwen Wang and Yan Zhang. Their work appears in journals such as Frontiers in Pharmacology, Carcinogenesis, Cancer Immunology Immunotherapy, Frontiers in Oncology and BMC Anesthesiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.